Screener Summaries Updates Institutions Sign In More Updates › Mergers & Acquisitions › LSTA Mergers & Acquisitions · Jul 17, 2026
Lisata Therapeutics, Inc. entered into an amendment to its previously announced merger agreement with Kuva Labs Inc.… LSTA Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. entered into an amendment to its previously announced merger agreement with Kuva Labs Inc. and Kuva Acquisition Corp. to extend the outside date of the transaction from July 17, 2026, to July 21, 2026. Lisata Therapeutics, Inc. operates in the biopharmaceutical industry and develops therapeutic solutions for various medical conditions.
More from Lisata Therapeutics, Inc. Lisata Therapeutics appoints Jeffrey Farrow to Board, expanding it from seven to eight members Oct 14, 2026 On September 17, 2026, Lisata Therapeutics completed its acquisition of Marea Therapeutics via a stock-for-stock merger Sep 17, 2026 Lisata Therapeutics announced a reduction in workforce by approximately 72%, effective immediately, to cut operating… Aug 4, 2026 Lisata Therapeutics, Inc. terminated its previously announced merger agreement with Kuva Labs Inc. and Kuva… Jul 24, 2026 Lisata Therapeutics, Inc. entered into an amendment to its Merger Agreement with Kuva Labs Inc. and Kuva Acquisition… Jun 9, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
